Experienced in Chronic Obstructive Pulmonary Disease (COPD)

Christopher Lambers

Ordensklinikum Linz Elisabethinen
Linz, AT 
Experienced in Chronic Obstructive Pulmonary Disease (COPD)
Ordensklinikum Linz Elisabethinen
Linz, AT 
OverviewLocationsClinical Research

Overview

Christopher Lambers practices in Linz, Austria. Mr. Lambers is rated as an Experienced expert by MediFind in the treatment of Chronic Obstructive Pulmonary Disease (COPD). His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, and Lung Transplant.

His clinical research consists of co-authoring 25 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Chronic Obstructive Pulmonary Disease (COPD).

Gender
Male

Locations

Ordensklinikum Linz Elisabethinen
Linz, 4020, Austria
Other Locations
Vienna, Austria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
Enrollment Status: Completed
Publish Date: October 15, 2025
Intervention Type: Biological, Drug, Device
Study Drugs: Depemokimab, Mepolizumab, Benralizumab
Study Phase: Phase 3

25 Total Publications

Glucocorticoid Insensitivity: Is It a Question of Time and Place?
Glucocorticoid Insensitivity: Is It a Question of Time and Place?
Journal: Biomedicines
Published: May 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lambers's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile